Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1071822Generated: November 2, 2026

m-Chloroperbenzoic acid → HCID 69732331, compound

https://huagongshe.com/reaction/1071822

Reaction equation

Participants

RoleNameHCIDCharge
Reactantm-Chloroperbenzoic acidHCID 70297—
ReactantHCID 69730436HCID 69730436—
ReactantHCID 131724998HCID 131724998—
ReactantHCID 131724999HCID 131724999—
ProductHCID 69732331HCID 69732331—

Reaction Steps

Finally, T. Aoki et al. (Tetrahedron 1983, 34/15, 2515-2556—in particular pages 2520-2525) disclose the synthesis of diphenylmethyl 7β-(2-thienylacetamino)-3-(1-methyl-1H-tetrazol-5-yl)thiometyl-3-cephem-4-carboxylate, which involves the preparation of diphenylmethyl 7β-(2-thienylacetamino)-3-(l-methyl-1H-tetrazol-5-yl)-3-methylthiocepham-4-carboxylate via the corresponding 3-methylthio-3-chloromethylcepham analog and the reaction of said diphenylmethyl 7β-(2-thienylacetamino)-3-(1-methyl-1H-tetrazol-5-yl)-3-methylthiocepham-4-carboxylate with m-chloroperbenzoic acid in order to remove methylmercaptan and form a 3-(1-methyl-1H-tetrazol-5-yl)-3-cephem structure via the corresponding 1-oxide. However, the method described by Aoki et al. is not transposable to the preparation of third-generation-cefalosporins because the reactants employed affect the amino group which is present on the thiazole ring and is sensitive thereto.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06906187B2
Source datasetuspto-grants-2005_06
ORD IDord-b4955aac6eb84df9ab933ddc1fcba28f
Source noteuspto-grants-2005_06